| chair | ||
|---|---|---|
| David H. Koch | Director & Executive Vice President | Koch Industries |
| members | ||
| Janice Bourque | Sr VP & Group Head Life Sciences | Comerica Bank |
| Earl M. Collier, Jr. | Executive Vice President | Genzyme Corporation |
| Janis K. Fraser | Principal | Fish & Richardson P.C. |
| Stephen Friend | Executive Vice President | Merck Research Laboratories |
| Nick G. Galakatos | Co-founder & Managing Director | Clarus Ventures |
| James Goodwin | Principal | James Goodwin, Inc. |
| Louise Grochow | Executive Director, Global Medical Science | AstraZeneca |
| Tuan Ha-Ngoc | President and CEO | AVEO Pharmaceuticals |
| William M. Haney III | Partner | Uncommon Productions |
| William A. Haseltine | President | William A. Haseltine Foundation for Medical Sciences and the Arts |
| Peter Hecht | CEO | Ironwood |
| Charles W. Johnson | Chairman | Visual Numerics, Inc. |
| Judy C. Lewent | Retired Executive Vice President & CF0 | Merck & Co., Inc. |
| Diana J. Mackie | Owner | Health Matters, International, LLC |
| Kiran Mazumdar-Shaw | Chairman & Managing Director | Biocon Limited |
| Terrance McGuire | Co-founder & Managing General Partner | Polaris Venture Partners |
| Frederick A. Middleton, Jr. | Managing Director | Sanderling Ventures |
| Thomas F. Peterson, Jr. | Retired Principal | Motion Picture Sound, Inc. |
| Barbara A. Piette | Managing Principal | Knightsbridge Advisers LLC |
| Richard S. Sackler | Co-Chairman | Purdue Pharma, L.P. |
| Stephen A. Scaringe | Founder | Dharmacon |
| Judy C. Swanson | Director | Swanson Foundation |
| Alison Taunton-Rigby | Founder & CEO | RiboNovix, Inc |
| Jay M. Tenenbaum | Chairman and Chief Scientist | CollabRx |
Our new, ultra-sensitive chip-based devices allow us to study changes in nanoparticles or living cells with over one million times greater precision than ever before.
